Laurent Choppe
Directeur Général chez Neurochem (International) Ltd.
Profil
Laurent Choppe is currently the Chief Executive Officer at Neurochem (International) Ltd.
and the Chairman at Cukierman & Co. Life Sciences.
He holds an MBA from INSEAD and a doctorate from Université Paris 1 Panthéon-Sorbonne.
Postes actifs de Laurent Choppe
| Sociétés | Poste | Début |
|---|---|---|
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Directeur Général | 01/09/2004 |
Cukierman & Co. Life Sciences
 Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Président | 01/01/2008 |
Formation de Laurent Choppe
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
| INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Neurochem (International) Ltd.
Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Commercial Services |
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Finance |
